Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial
Background and Objectives Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse betw...
Gespeichert in:
Veröffentlicht in: | The American journal on addictions 2021-09, Vol.30 (5), p.433-444 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 444 |
---|---|
container_issue | 5 |
container_start_page | 433 |
container_title | The American journal on addictions |
container_volume | 30 |
creator | Fishman, Marc Wenzel, Kevin Scodes, Jennifer Pavlicova, Martina Campbell, Aimee N. C. Rotrosen, John Nunes, Edward |
description | Background and Objectives
Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse between age groups.
Methods
This secondary analysis compared young adults (18‐25) to older adults (26+) from a comparative effectiveness trial (“XBOT”) that randomized (N = 570) participants to extended‐release naltrexone or sublingual buprenorphine‐naloxone. We explored the relationship between 25 prespecified patient baseline characteristics and relapse to regular opioid use by age group and treatment condition, using logistic regression.
Results
Young adults (n = 111) had higher rates of 24‐week relapse than older adults (n = 459) (70.3% vs 58.8%) and differed on a number of specific characteristics, including more smokers, more intravenous opioid use, and more cannabis use. No significant moderators predicted relapse, in either three‐way or two‐way interactions.
Conclusions and Scientific Significance
No baseline factors were identified as moderating the relationship between age group and opioid relapse, nor any interactions between baseline characteristics, age group, and treatment condition to predict opioid relapse. Poorer treatment outcomes for young adults are likely associated with multiple developmental vulnerabilities rather than any single predominant factor. Although not reaching significance, several characteristics (using heroin, smoking tobacco, high levels of depression/anxiety, or treatment because of family/friends) showed higher odds ratio point estimates for relapse in young adults than older adults. This is the first study to explore moderators of worse OUD treatment outcomes in young adults, highlighting the need to identify predictor variables that could inform treatment enhancements. (Am J Addict 2021;00:1‐12) |
doi_str_mv | 10.1111/ajad.13176 |
format | Article |
fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8429062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AJAD13176</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4206-e736a205c03807f920e4f27a034f023d3da68c691d3bfcdc944fb7763d8cc7113</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEYmNw4QegnJE6kiZNWw5IZR98aNIObBKcoixJt0xtMyUdsH9PRwHBBV9sy68fWy8A5xj1cRNXYi1UHxMcswPQxVGIA0RSfNjUKIoCRFPWASfer1ETScqOQYdQFEeM0i4Qo3dRmkrUxlbQ5nBgndOFqLXfd9P5EE63tbRl05sKvthttYSZ2ha1v4ZPWtpKCbeDWSWKnTcejp0tYb3S8Pl2OoMzZ0RxCo5yUXh99pV7YD4ezQb3wWR69zDIJoGkIWKBjgkTIYokIgmK8zREmuZhLBChOQqJIkqwRLIUK7LIpZIppfkijhlRiZQxxqQHblruZrsotZK6qp0o-MaZsnmRW2H430llVnxpX3lCwxSxsAFctgDprPdO5z-7GPG90XxvNP80uhFf_L72I_12thHgVvBmCr37B8Wzx2zYQj8AO4OJJg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Fishman, Marc ; Wenzel, Kevin ; Scodes, Jennifer ; Pavlicova, Martina ; Campbell, Aimee N. C. ; Rotrosen, John ; Nunes, Edward</creator><creatorcontrib>Fishman, Marc ; Wenzel, Kevin ; Scodes, Jennifer ; Pavlicova, Martina ; Campbell, Aimee N. C. ; Rotrosen, John ; Nunes, Edward</creatorcontrib><description>Background and Objectives
Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse between age groups.
Methods
This secondary analysis compared young adults (18‐25) to older adults (26+) from a comparative effectiveness trial (“XBOT”) that randomized (N = 570) participants to extended‐release naltrexone or sublingual buprenorphine‐naloxone. We explored the relationship between 25 prespecified patient baseline characteristics and relapse to regular opioid use by age group and treatment condition, using logistic regression.
Results
Young adults (n = 111) had higher rates of 24‐week relapse than older adults (n = 459) (70.3% vs 58.8%) and differed on a number of specific characteristics, including more smokers, more intravenous opioid use, and more cannabis use. No significant moderators predicted relapse, in either three‐way or two‐way interactions.
Conclusions and Scientific Significance
No baseline factors were identified as moderating the relationship between age group and opioid relapse, nor any interactions between baseline characteristics, age group, and treatment condition to predict opioid relapse. Poorer treatment outcomes for young adults are likely associated with multiple developmental vulnerabilities rather than any single predominant factor. Although not reaching significance, several characteristics (using heroin, smoking tobacco, high levels of depression/anxiety, or treatment because of family/friends) showed higher odds ratio point estimates for relapse in young adults than older adults. This is the first study to explore moderators of worse OUD treatment outcomes in young adults, highlighting the need to identify predictor variables that could inform treatment enhancements. (Am J Addict 2021;00:1‐12)</description><identifier>ISSN: 1055-0496</identifier><identifier>EISSN: 1521-0391</identifier><identifier>DOI: 10.1111/ajad.13176</identifier><identifier>PMID: 34075644</identifier><language>eng</language><publisher>England</publisher><subject>Aged ; Analgesics, Opioid - therapeutic use ; Buprenorphine, Naloxone Drug Combination - therapeutic use ; Delayed-Action Preparations - therapeutic use ; Humans ; Naltrexone - therapeutic use ; Opiate Substitution Treatment ; Opioid-Related Disorders - drug therapy ; Young Adult</subject><ispartof>The American journal on addictions, 2021-09, Vol.30 (5), p.433-444</ispartof><rights>2021 American Academy of Addiction Psychiatry</rights><rights>2021 American Academy of Addiction Psychiatry.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4206-e736a205c03807f920e4f27a034f023d3da68c691d3bfcdc944fb7763d8cc7113</citedby><cites>FETCH-LOGICAL-c4206-e736a205c03807f920e4f27a034f023d3da68c691d3bfcdc944fb7763d8cc7113</cites><orcidid>0000-0002-6299-7569 ; 0000-0003-4247-9980 ; 0000-0001-6764-6410 ; 0000-0002-2055-3425</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajad.13176$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajad.13176$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34075644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fishman, Marc</creatorcontrib><creatorcontrib>Wenzel, Kevin</creatorcontrib><creatorcontrib>Scodes, Jennifer</creatorcontrib><creatorcontrib>Pavlicova, Martina</creatorcontrib><creatorcontrib>Campbell, Aimee N. C.</creatorcontrib><creatorcontrib>Rotrosen, John</creatorcontrib><creatorcontrib>Nunes, Edward</creatorcontrib><title>Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial</title><title>The American journal on addictions</title><addtitle>Am J Addict</addtitle><description>Background and Objectives
Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse between age groups.
Methods
This secondary analysis compared young adults (18‐25) to older adults (26+) from a comparative effectiveness trial (“XBOT”) that randomized (N = 570) participants to extended‐release naltrexone or sublingual buprenorphine‐naloxone. We explored the relationship between 25 prespecified patient baseline characteristics and relapse to regular opioid use by age group and treatment condition, using logistic regression.
Results
Young adults (n = 111) had higher rates of 24‐week relapse than older adults (n = 459) (70.3% vs 58.8%) and differed on a number of specific characteristics, including more smokers, more intravenous opioid use, and more cannabis use. No significant moderators predicted relapse, in either three‐way or two‐way interactions.
Conclusions and Scientific Significance
No baseline factors were identified as moderating the relationship between age group and opioid relapse, nor any interactions between baseline characteristics, age group, and treatment condition to predict opioid relapse. Poorer treatment outcomes for young adults are likely associated with multiple developmental vulnerabilities rather than any single predominant factor. Although not reaching significance, several characteristics (using heroin, smoking tobacco, high levels of depression/anxiety, or treatment because of family/friends) showed higher odds ratio point estimates for relapse in young adults than older adults. This is the first study to explore moderators of worse OUD treatment outcomes in young adults, highlighting the need to identify predictor variables that could inform treatment enhancements. (Am J Addict 2021;00:1‐12)</description><subject>Aged</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Buprenorphine, Naloxone Drug Combination - therapeutic use</subject><subject>Delayed-Action Preparations - therapeutic use</subject><subject>Humans</subject><subject>Naltrexone - therapeutic use</subject><subject>Opiate Substitution Treatment</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Young Adult</subject><issn>1055-0496</issn><issn>1521-0391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PwzAMhiMEYmNw4QegnJE6kiZNWw5IZR98aNIObBKcoixJt0xtMyUdsH9PRwHBBV9sy68fWy8A5xj1cRNXYi1UHxMcswPQxVGIA0RSfNjUKIoCRFPWASfer1ETScqOQYdQFEeM0i4Qo3dRmkrUxlbQ5nBgndOFqLXfd9P5EE63tbRl05sKvthttYSZ2ha1v4ZPWtpKCbeDWSWKnTcejp0tYb3S8Pl2OoMzZ0RxCo5yUXh99pV7YD4ezQb3wWR69zDIJoGkIWKBjgkTIYokIgmK8zREmuZhLBChOQqJIkqwRLIUK7LIpZIppfkijhlRiZQxxqQHblruZrsotZK6qp0o-MaZsnmRW2H430llVnxpX3lCwxSxsAFctgDprPdO5z-7GPG90XxvNP80uhFf_L72I_12thHgVvBmCr37B8Wzx2zYQj8AO4OJJg</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Fishman, Marc</creator><creator>Wenzel, Kevin</creator><creator>Scodes, Jennifer</creator><creator>Pavlicova, Martina</creator><creator>Campbell, Aimee N. C.</creator><creator>Rotrosen, John</creator><creator>Nunes, Edward</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6299-7569</orcidid><orcidid>https://orcid.org/0000-0003-4247-9980</orcidid><orcidid>https://orcid.org/0000-0001-6764-6410</orcidid><orcidid>https://orcid.org/0000-0002-2055-3425</orcidid></search><sort><creationdate>202109</creationdate><title>Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial</title><author>Fishman, Marc ; Wenzel, Kevin ; Scodes, Jennifer ; Pavlicova, Martina ; Campbell, Aimee N. C. ; Rotrosen, John ; Nunes, Edward</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4206-e736a205c03807f920e4f27a034f023d3da68c691d3bfcdc944fb7763d8cc7113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Buprenorphine, Naloxone Drug Combination - therapeutic use</topic><topic>Delayed-Action Preparations - therapeutic use</topic><topic>Humans</topic><topic>Naltrexone - therapeutic use</topic><topic>Opiate Substitution Treatment</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fishman, Marc</creatorcontrib><creatorcontrib>Wenzel, Kevin</creatorcontrib><creatorcontrib>Scodes, Jennifer</creatorcontrib><creatorcontrib>Pavlicova, Martina</creatorcontrib><creatorcontrib>Campbell, Aimee N. C.</creatorcontrib><creatorcontrib>Rotrosen, John</creatorcontrib><creatorcontrib>Nunes, Edward</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal on addictions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fishman, Marc</au><au>Wenzel, Kevin</au><au>Scodes, Jennifer</au><au>Pavlicova, Martina</au><au>Campbell, Aimee N. C.</au><au>Rotrosen, John</au><au>Nunes, Edward</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial</atitle><jtitle>The American journal on addictions</jtitle><addtitle>Am J Addict</addtitle><date>2021-09</date><risdate>2021</risdate><volume>30</volume><issue>5</issue><spage>433</spage><epage>444</epage><pages>433-444</pages><issn>1055-0496</issn><eissn>1521-0391</eissn><abstract>Background and Objectives
Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse between age groups.
Methods
This secondary analysis compared young adults (18‐25) to older adults (26+) from a comparative effectiveness trial (“XBOT”) that randomized (N = 570) participants to extended‐release naltrexone or sublingual buprenorphine‐naloxone. We explored the relationship between 25 prespecified patient baseline characteristics and relapse to regular opioid use by age group and treatment condition, using logistic regression.
Results
Young adults (n = 111) had higher rates of 24‐week relapse than older adults (n = 459) (70.3% vs 58.8%) and differed on a number of specific characteristics, including more smokers, more intravenous opioid use, and more cannabis use. No significant moderators predicted relapse, in either three‐way or two‐way interactions.
Conclusions and Scientific Significance
No baseline factors were identified as moderating the relationship between age group and opioid relapse, nor any interactions between baseline characteristics, age group, and treatment condition to predict opioid relapse. Poorer treatment outcomes for young adults are likely associated with multiple developmental vulnerabilities rather than any single predominant factor. Although not reaching significance, several characteristics (using heroin, smoking tobacco, high levels of depression/anxiety, or treatment because of family/friends) showed higher odds ratio point estimates for relapse in young adults than older adults. This is the first study to explore moderators of worse OUD treatment outcomes in young adults, highlighting the need to identify predictor variables that could inform treatment enhancements. (Am J Addict 2021;00:1‐12)</abstract><cop>England</cop><pmid>34075644</pmid><doi>10.1111/ajad.13176</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-6299-7569</orcidid><orcidid>https://orcid.org/0000-0003-4247-9980</orcidid><orcidid>https://orcid.org/0000-0001-6764-6410</orcidid><orcidid>https://orcid.org/0000-0002-2055-3425</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1055-0496 |
ispartof | The American journal on addictions, 2021-09, Vol.30 (5), p.433-444 |
issn | 1055-0496 1521-0391 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8429062 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Aged Analgesics, Opioid - therapeutic use Buprenorphine, Naloxone Drug Combination - therapeutic use Delayed-Action Preparations - therapeutic use Humans Naltrexone - therapeutic use Opiate Substitution Treatment Opioid-Related Disorders - drug therapy Young Adult |
title | Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A29%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Examination%20of%20Correlates%20of%20OUD%20Outcomes%20in%20Young%20Adults:%20Secondary%20Analysis%20From%20the%20XBOT%20Trial&rft.jtitle=The%20American%20journal%20on%20addictions&rft.au=Fishman,%20Marc&rft.date=2021-09&rft.volume=30&rft.issue=5&rft.spage=433&rft.epage=444&rft.pages=433-444&rft.issn=1055-0496&rft.eissn=1521-0391&rft_id=info:doi/10.1111/ajad.13176&rft_dat=%3Cwiley_pubme%3EAJAD13176%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34075644&rfr_iscdi=true |